Differential associations of traditional and non-traditional risk factors with carotid intima-media thickening and plaque in peritoneal dialysis patients

American Journal of Nephrology

Volumn 27, Issue 5, 2007, Pages 458-465

  Wang, Angela Yee Moon ^a,b   Ho, Stella Sin Yee ^a   Liu, Eric Kin Hung ^a   Chan, Iris Hiu Shuen ^a   Ho, Simon ^a   Sanderson, John E ^a   Lam, Christopher Wai Kei ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

C reactive protein; Calcium; Carotid; Intima media; Peritoneal dialysis; Plaque

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CALCIUM; FETUIN; FETUIN A; FIBRINOGEN; LIPOPROTEIN A; UNCLASSIFIED DRUG;

ADULT; AGE; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD ANALYSIS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CAROTID ARTERY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; UNIVARIATE ANALYSIS;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCIUM; CAROTID ARTERIES; CAROTID STENOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PREVALENCE; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 34748885602     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106457     Document Type: Article

References (35)

1. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G: Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 1996;28:713-720.
2. Papagianni A, Kokolina E, Kalovoulos M, Vainas A, Dimitriadis C, Memmos D: Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004;19:1258-1263.
3. Malatino LS, Benedetto FA, Mallamaci F, Tripepi G, Zoccali C, Parlongo S, Cutrupi S, Marino C, Panuccio V, Garozzo M, Candela V, Bellanuova I, Cataliotti A, Rapisarda F, Fatuzzo P, Bonanno G, Seminara G, Stancanelli B, Tassone F, Labate C: Smoking, blood pressure and serum albumin are major determinants of carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Nephrol 1999;12:256-260.
4. Malatino LS, Mallamaci F, Benedetto FA, Bellanuova I, Cataliotti A, Tripepi G, Zoccali C: Hepatocyte growth factor predicts survival and relates to inflammation and intima media thickness in end-stage renal disease. Am J Kidney Dis 2000;36:945-952.
5. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Foca A, Paroni R, Malatino LS: Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000;18:1207-1213.
6. Erten Y, Ozturk MA, Oktar S, Pasaoglu H, Reis KA, Derici U, Elbeg S, Guz G, Bali M, Arinsoy T, Sindel S: Association between neopterin and carotid intima-media thickness in hemodialysis patients. Nephron Clin Pract 2005;101:c134-c138.
7. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A: Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002;61:1143-1152.
8. Sakurabayashi T, Fujimoto M, Takaesu Y, Haginoshita S, Goto S, Aoike I, Miyazaki S, Koda Y, Yuasa Y, Sakai S, Suzuki M, Hirasawa Y: Association between plasma homocysteine concentration and carotid atherosclerosis in hemodialysis patients. Jpn Circ J 1999;63:692-696.
9. Ohkuma T, Minagawa T, Takada N, Ohno M, Oda H, Ohashi H: C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients. Am J Kidney Dis 2003;42:355-361.
10. Berglund GL: Ultrasound in clinical trials of atherosclerosis. J Intern Med 1994;236:551-553.
11. Matthews KA, Kuller LH, Sutton-Tyrrell K, Chang YF: Changes in cardiovascular risk factors during the perimenopause and postmenopause and carotid artery atherosclerosis in healthy women. Stroke 2001;32:1104-1111.
12. Hunt KJ, Evans GW, Folsom AR, Sharrett AR, Chambless LE, Tegeler CH, Heiss G: Acoustic shadowing on B-mode ultrasound of the carotid artery predicts ischemic stroke - the atherosclerosis risk in communities (ARIC) study. Stroke 2001;32:1120-1126.
13. Nolph KD, Moore HL, Twardowski ZJ, Khanna R, Prowant B, Meyer M, Ponferrada L: Cross-sectional assessment of weekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. ASAIO J 1992;38:M139-M142.
14. Mak TW, Cheung CK, Cheung CM, Leung CB, Lam CW, Lai KN: Interference of creatinine measurement in CAPD fluid is dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997;12:184-186.
15. van Olden RW, Krediet RT, Struijk DG, Arisz L: Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1996;7:745-750.
16. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-733.
17. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658.
18. Makita S, Nakamura M, Hiramori K: The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005;36:2138-2142.
19. Toss H, Lindahl B, Siegbahn A, Wallentin L: Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 1997;96:4204-4210.
20. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998;18:1386-1392.
21. Yasojima K, Schwab C, McGeer EG, McGeer PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001;158:1039-1051.
22. Lombardo A, Biasucci LM, Lanza GA, Coli S, Silvestri P, Cianflone D, Liuzzo G, Burzotta F, Crea F, Maseri A: Inflammation as a possible link between coronary and carotid plaque instability. Circulation 2004;109:3158-3163.
23. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
24. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
25. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE: Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Nephrol Dial Transplant 1998;13:2004-2012.
26. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000;15:218-223.
27. Yildiz A, Tepe S, Oflaz H, Yazici H, Pusuroglu H, Besler M, Ark E, Erzengin F: Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant 2004;19:885-891.
28. Kronenberg F, Konig P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H: Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6:110-120.
29. Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS, Witztum JL, Berger PB: Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005;353:46-57.
30. Ohashi H, Oda H, Ohno M, Watanabe S, Sakata S: Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients. Kidney Int Suppl 1999;71:S242-S244.
31. Koch M, Kutkuhn B, Trenkwalder E, Bach D, Grabensee B, Dieplinger H, Kronenberg F: Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients. J Am Soc Nephrol 1997;8:1889-1898.
32. Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL, Wade DP, Lawn RM: Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993;260:1655-1658.
33. Beisiegel U, Niendorf A, Wolf K, Reblin T, Rath M: Lipoprotein(a) in the arterial wall. Eur Heart J 1990;11(suppl E):174-183.
34. Lundman P, Keech AC, Griffiths K, Pillai A, Celermajer DS: New carotid plaque formation is very common in adult patients with type 2 diabetes mellitus. Diabet Med 2005;22:355-356.
35. Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R: Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004;24:1266-1271.